Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Assets (2021 - 2025)

Verrica Pharmaceuticals has reported Return on Assets over the past 5 years, most recently at 0.43% for Q4 2025.

  • Quarterly results put Return on Assets at 0.43% for Q4 2025, up 127.0% from a year ago — trailing twelve months through Dec 2025 was 0.43% (up 127.0% YoY), and the annual figure for FY2025 was 0.38%, up 71.0%.
  • Return on Assets for Q4 2025 was 0.43% at Verrica Pharmaceuticals, up from 0.61% in the prior quarter.
  • Over the last five years, Return on Assets for VRCA hit a ceiling of 0.34% in Q2 2023 and a floor of 2.0% in Q3 2024.
  • Median Return on Assets over the past 5 years was 0.61% (2025), compared with a mean of 0.85%.
  • Biggest five-year swings in Return on Assets: crashed -140bps in 2024 and later soared 140bps in 2025.
  • Verrica Pharmaceuticals' Return on Assets stood at 0.42% in 2021, then fell by -18bps to 0.49% in 2022, then plummeted by -53bps to 0.75% in 2023, then plummeted by -127bps to 1.7% in 2024, then skyrocketed by 75bps to 0.43% in 2025.
  • The last three reported values for Return on Assets were 0.43% (Q4 2025), 0.61% (Q3 2025), and 1.15% (Q2 2025) per Business Quant data.